Selecta Biosciences Inc.

3.67-0.0100-0.27%Vol 637.62K1Y Perf 82.60%
May 29th, 2020 16:00 DELAYED
BID3.69 ASK3.70
Open3.70 Previous Close3.68
Pre-Market- After-Market3.68
 - -%  0.01 0.27%
Target Price
7.80 
Analyst Rating
Strong Buy 1.00
Potential %
112.53 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-33/20 
Value Ranking
 —    -
Insiders Value % 3/6/12 mo.
-13/-55/12 
Growth Ranking
★+     41.14
Insiders Shares Cnt. % 3/6/12 mo.
19/-56/17 
Income Ranking
 —    -
Market Cap321.09M 
Earnings Rating
Sell
Price Range Ratio 52W %
67.32 
Earnings Date
7th May 2020

Today's Price Range

3.673.85

52W Range

1.284.83

Summary:

Buy

Technical Indicators: Neutral
Moving Averages: Strong Buy
Performance
1 Week
-6.38%
1 Month
35.93%
3 Months
-8.25%
6 Months
123.78%
1 Year
82.60%
3 Years
-73.19%
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
SELB3.67-0.0100-0.27
AAPL317.94-0.3100-0.10
GOOG1 428.9212.19000.86
MSFT183.251.85001.02
XOM45.470.43000.95
WFC26.47-0.7500-2.76
JNJ148.751.78001.21
FB225.09-0.3700-0.16
GE6.57-0.2100-3.10
JPM97.31-2.5500-2.55
Financial StrengthValueIndustryS&P 500US Markets
2.40
2.50
-
2.30
-44.10
Leverage Ratio -52.60
ProfitabilityValueIndustryS&P 500US Markets
-
-922.50
-891.30
-7 976.40
-
RevenueValueIndustryS&P 500US Markets
6.67M
0.08
47.02
-1.59
Earnings HistoryEstimateReportedSurprise %
Q01 2020-0.27-0.2122.22
Q04 2019-0.19-0.28-47.37
Q03 2019-0.28-0.267.14
Q02 2019-0.34-0.37-8.82
Q01 2019-0.37-0.3116.22
Q04 2018-0.76-0.6514.47
Q03 2018-0.79-0.7110.13
Q02 2018-0.72-0.84-16.67
Earnings Per EndEstimateRevision %Trend
6/2020 QR-0.209.09Positive
9/2020 QR-0.195.00Positive
12/2020 FY-0.81-19.12Negative
12/2021 FY-0.80-9.59Negative
Next Report Date-
Estimated EPS Next Report-0.27
Estimates Count4
EPS Growth Next 5 Years %-
Volume Overview
Volume637.62K
Shares Outstanding87.49M
Trades Count3.81K
Dollar Volume2.45M
Avg. Volume742.37K
Avg. Weekly Volume571.70K
Avg. Monthly Volume797.90K
Avg. Quarterly Volume794.00K

Selecta Biosciences Inc. (NASDAQ: SELB) stock closed at 3.67 per share at the end of the most recent trading day (a -0.27% change compared to the prior day closing price) with a volume of 638.29K shares and market capitalization of 321.09M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 39 people. Selecta Biosciences Inc. CEO is Carsten Brunn.

The one-year performance of Selecta Biosciences Inc. stock is 82.6%, while year-to-date (YTD) performance is 54.2%. SELB stock has a five-year performance of %. Its 52-week range is between 1.28 and 4.83, which gives SELB stock a 52-week price range ratio of 67.32%

Selecta Biosciences Inc. currently has a PE ratio of -, a price-to-book (PB) ratio of 32.61, a price-to-sale (PS) ratio of 51.44, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -83.15%, a ROC of -182.90% and a ROE of -2 077.15%. The company’s profit margin is -%, its EBITDA margin is -891.30%, and its revenue ttm is $6.67 Million , which makes it $0.08 revenue per share.

Of the last four earnings reports from Selecta Biosciences Inc., there were 2 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $-0.27 for the next earnings report. Selecta Biosciences Inc.’s next earnings report date is -.

The consensus rating of Wall Street analysts for Selecta Biosciences Inc. is Strong Buy (1), with a target price of $7.8, which is +112.53% compared to the current price. The earnings rating for Selecta Biosciences Inc. stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Selecta Biosciences Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Selecta Biosciences Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 27.29, ATR14 : 0.33, CCI20 : 74.38, Chaikin Money Flow : 0.02, MACD : 0.28, Money Flow Index : 46.31, ROC : 8.58, RSI : 61.44, STOCH (14,3) : 49.59, STOCH RSI : 0.00, UO : 44.24, Williams %R : -50.41), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Selecta Biosciences Inc. in the last 12-months were: Carsten Brunn (Option Excercise at a value of $0), Carsten Brunn (Sold 17 646 shares of value $34 821 ), Lloyd Johnston (Option Excercise at a value of $7 110), Timothy A. Springer (Buy at a value of $17 415), Timothy C. Barabe (Buy at a value of $27 200)

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
6 (100.00 %)
5 (100.00 %)
5 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

Selecta Biosciences Inc.

Selecta Biosciences Inc is a clinical-stage biopharmaceutical company. The company is engaged in using synthetic vaccine particle or SVP technology to discover and develop targeted therapies to modulate the immune system effectively and safely treat rare and serious diseases. It provides SVP for immune tolerance and stimulation. The company products in Phase 1 and Phase 2 include SEL-403 for Pancreatic Cancer and Mesothelioma, SEL-212 for Chronic Severe Gout, SEL-302 for Methylmalonic Acidemia (MMA) and SEL-313 for Ornithine Transcarbamylase Deficiency (OTC).

CEO: Carsten Brunn

Teplephone: +1 617 923-1400

Address: 480 Arsenal Way, Watertown 02472, MA, USA

Number of employees: 39

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

0%100%

Bearish Bullish

63%38%

Bearish Bullish

40%60%

Bearish Bullish

49%51%

News

Stocktwits